Uncategorized
Eleven Biotherapeutics reports increase in revenue in 2014
Eleven Biotherapeutics reported total revenue of $2.2 million in 2014 compared with $1.3 million in 2013, according to a press release.Net loss applicable to common stockholders was reported at $34.7 million, or $2.37 per share, in 2014 compared with $21.9 million, or $16.18 per share, in 2013.